US equities |
META $620.19 ▼-1.64% MU $928.76 ▲+2.77% NVDA $217.94 ▲+0.90% TSLA $407.46 ▲+4.04% SPCX $148.58 ▲+1.14% AAPL $347.10 ▲+0.93% AMD $560.26 ▲+5.45% MSFT $531.33 ▼-0.24%
FinancialContent

Latest News about Fragile X Syndrome

Recent news which mentions Fragile X Syndrome

Psychedelics And The Spectrum: Groundbreaking Study Details How One Firm Approaches Autism
Tickers NMLSF
Tags Fragile X Syndrome Markets Market News
From Benzinga
Health Canada Grants Exemption: Phase 2 Trial On Psilocybin For Genetic Disorder
Tickers KONEF NMLSF
Tags Benzinga NMLSF News
From Benzinga
First-Ever Clinical Trial On Magic Mushroom Therapy For Autism's Genetic Cause Receives Approval
Tickers KONEF NMLSF
Tags Fragile X Syndrome Markets Psychedelics
From Benzinga